OncoReason: Structuring Clinical Reasoning in LLMs for Robust and Interpretable Survival Prediction
Raghu Vamshi Hemadri · 2025
Read OncoReason: Structuring Clinical Reasoning in LLMs for Robust and Interpretable Survival Prediction by Raghu Vamshi Hemadri (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2510-17532.txt.
Introduction
Raghu Vamshi Hemadri, with Geetha Krishna Guruju and two co-authors, trains cancer outcome models in a 2025 arXiv paper. Doctors need models that predict survival and also explain their reasoning in plain clinical terms. The team built one system that learns three tasks at once from a large cancer dataset. It classifies survival, estimates survival time, and writes a short rationale for each call.
Three training styles were compared on two model backbones. Step by step prompting lifted accuracy and cut time errors. A reward based method that favors expert like reasoning scored best on both prediction and explanation quality. The work shows that teaching models to reason openly can make cancer predictions more trustworthy.
Catalog record
| CREATOR | Raghu Vamshi Hemadri |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2510-17532
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
OncoReason: Structuring Clinical Reasoning in LLMs for Robust and Interpretable Survival Prediction Raghu Vamshi Hemadri Abstract Predicting cancer treatment outcomes requires models that are both accurate and interpretable, particularly in the presence of heterogeneous clinical data. While large language models (LLMs) have shown strong performance in biomedical NLP, they often lack structured reasoning capabilities critical for high-stakes decision support. We present a unified, multi-task learning framework that aligns autoregressive LLMs with clinical reasoning for outcome prediction on the MSK-CHORD dataset. Our models are trained to jointly perform binary survival classification, continuous survival time regression, and natural language rationale generation. We evaluate three alignment strategies: (1) standard supervised fine-tuning (SFT), (2) SFT with Chain-of-Thought (CoT) prompting to elicit step-by-step reasoning, and (3) Group Relative Policy Optimization (GRPO), a reinforcement learning method that aligns model outputs to expert-derived reasoning trajectories. Experiments with LLaMa3-8B and Med42-8B backbones demonstrate that CoT prompting improves F1 by +6.0 and reduces MAE by 12%, while GRPO achieves state-of-the-art interpretability and predictive performance across BLEU, ROUGE, and BERTScore. We further show that existing biomedical LLMs often fail to produce valid reasoning traces due to architectural constraints. Our findings underscore the importance of reasoning-aware alignment in multi-task clinical modeling and set a new benchmark for interpretable, trustworthy LLMs in precision oncology. Introduction Cancer remains one of the most complex and heterogeneous diseases, with treatment outcomes varying dramatically across patients, even within the same diagnostic category ( Hanahan and Weinberg 2011 ; Marusyk, Almendro, and Polyak 2012 ) . Clinical decisions, such as therapy selection, outcome prediction, and risk assessment, rely on physician experience, clinical guidelines, and population models ( Topol 2019 ) . However, these approaches often fall short in personalizing treatment or explaining predictions, especially in rare or high-risk cases ( Esteva et al. 2019 ; Yala et al. 2021 ) . While EHRs, radiology, and pathology data contain valuable context, much of this information remains underused due to its unstructured nature ( Jensen, Jensen, and Brunak 2012 ; Alsentzer et al. 2019 ) . Traditional models like Cox regression and GBDTs handle structured features well but fail to incorporate long-range dependencies and semantic richness from clinical narratives ( Rajkomar et al. 2018 ; Boag et al. 2018 ) . Moreover, their opaque predictions hinder interpretability, which is crucial for real-world oncology ( Caruana et al. 2015 ; Tonekaboni et al. 2019 ) . LLMs pretrained on biomedical corpora offer a pathway to integrate structured and unstructured data into a unified representation. Models such as Med42-8B ( Christophe et al. 2024 ) , Meditron ( Chen et al. 2023 ) , and OpenBio ( Ankit Pal 2024 ) have shown promise in biomedical tasks like QA and summarization, yet are not optimized for structured clinical inference and explainability. Figure 1: From Black-Box Models to Reasoning-Augmented LLMs for Cancer Outcome Prediction. Existing LLMs excel at general biomedical tasks but lack structured clinical reasoning and explainability. Our proposed framework augments LLMs with Chain-of-Thought (CoT) prompting and GRPO-based alignment to perform interpretable, multi-task survival prediction on MSK-CHORD. Figure 1 illustrates a key limitation of existing LLMs in oncology: while they can predict survival status or duration (e.g., “Living: 6 months”), they often fail to provide clinical justifications, reducing interpretability. To address this gap, we propose OncoReason , a reasoning-aligned LLM framework designed to generate patient-specific rationales alongside outcome predictions, enhancing transparency in high-stakes cancer care. We fine-tune open-source LLM backbones ( LLaMa3-8B , Med42-8B ) on the MSK-CHORD dataset ( Jee et al. 2024 ) using a unified, auto-regressive multi-task protocol that jointly predicts (1) binary survival status, (2) continuous survival months, and (3) natural language Chain-of-Thought (CoT) rationales. To assess the impact of reasoning-aware learning, we compare three training strategies: (1) Supervised Fine-Tuning (SFT) without CoT, (2) SFT with CoT prompting ( Wei et al. 2022 ) , and (3) Group Relative Policy Optimization (GRPO), a reinforcement-based alignment method that uses diverse CoT exemplars to encourage causal and calibrated inference ( Shao et al. 2024 ) . We show that reasoning-augmented models significantly outperform strong biomedical LLM baselines across classification, regression, and generation metrics, while also improving the semantic fidelity and reliability of model explanations ( Huang et al. 2023 ) . Our contributions are summarized as follows: • We propose a unified training pipeline for jointly modeling survival status, survival duration, and Chain-of-Thought reasoning in cancer outcome prediction. • We conduct extensive evaluations on the MSK-CHORD dataset, showing that our reasoning-enhanced models outperform leading clinical LLMs on all fronts, including precision, MAE/RMSE, BLEU, ROUGE, and BERTScore. Our work paves the way for next-generation clinical AI systems that not only predict outcomes but also communicate the rationale behind each decision, making them more trustworthy and robust in real-world oncology workflows. Related Work Treatment outcome prediction involves forecasting the results of medical interventions, aiming to anticipate a patient’s response to a specific treatment regimen. In oncology, this task is especially significant due to the heterogeneity of cancer types and patient responses. Predictive models help identify which patients may benefit from therapies such as chemotherapy, immunotherapy, or targeted treatments, enabling personalized care. Treatment outcome prediction has traditionally relied on statistical and machine learning models. Traditional statistical approaches like Cox regression ( Cox 1992 ) and logistic regression ( Hos 2000 ) are valued for simplicity and interpretability but often make strong assumptions (e.g., linearity or proportional hazards) and may underperform in high-dimensional settings. Tree-based models like Random Forests and XGBoost ( Breiman 2001 ; Friedman 2001 ) capture nonlinear patterns and improve performance, but at the cost of interpretability. Recent advances in deep learning have transformed outcome prediction by enabling models to capture complex, high-dimensional patterns. CNNs have proven effective in medical imaging by extracting hierarchical features, though their reliance on annotated data and opaque predictions limits clinical trust ( Litjens et al. 2017 ) . Hybrid approaches have integrated structured variables with imaging data ( Sonntag and Profitlich 2019 ) . Models like Deep Patient ( Zhang et al. 2016 ) and Doctor AI ( Kazachkov 2015 ) have leveraged unsupervised and sequential learning from EHRs to forecast patient trajectories. The emergence of large language models (LLMs) has also significantly advanced NLP in medicine. GPT-4 has enabled complex tasks such as diagnostic reasoning and risk assessment ( OpenAI and et. al. 2024 ) , while Med-PaLM has reached near-human performance in medical QA ( Zitu et al. 2024 ) . Biomedical-adapted models such as BioBERT and ClinicalBERT ( Nazi and Peng 2024 ) have improved diagnosis and summarization through pretraining on clinical corpora. More recently, LLMs have been applied to treatment outcome prediction using both structured and unstructured inputs. Prompting-based methods enable zero-shot forecasting of outcomes like mortality and readmission ( Zhu et al. 2024 ) , and domain-adapted models like Meditron , OpenBio , and Med42-8B have become strong clinical baselines. Several studies have explored LLMs in oncology and prognosis: ( PMC 2023 ) focused on biomarker analysis; ( Chen and Brown 2023 ) compared transformers with traditional models; and ( Naik, Feldman, and Hope 2021 ; Zheng, Xu, and Fu 2024 ; Shoham 2023 ; Zakka and Chaurasia 2023 ) proposed multimodal and guideline-integrated frameworks for forecasting and recommendations.